Search research articles
Contact Us
Filters
Showing results (91-100 of 272) with videos related to
Page
of 28
Sort By:
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
December 27, 2018
Diffuse Idiopathic Skeletal Hyperostosis, Associated Morbidity, and Healthcare Utilization: A University Hospital Experience
Maanas Tripathi, Divya Rajmohan, Cody Quirk, et al.
Springerplus
|
March 21, 2015
Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy
Kathryn Hobbs, Atul Deodhar, Brian Wang, et al.
JAMA Network Open
|
January 16, 2019
Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin
Daniel M Hartung, Kirbee Johnston, David M Cohen, et al.
Arthritis Research & Therapy
|
May 24, 2024
Time to improvement of pain, morning stiffness, fatigue, and disease activity in patients with ankylosing spondylitis treated with tofacitinib: a post hoc analysis
Victoria Navarro-Compán, Atul Deodhar, Rachid Bahiri, et al.
Arthritis Care & Research
|
June 29, 2012
Comparison of three methods for calculating the Bath Ankylosing Spondylitis Metrology Index in a randomized placebo-controlled study
Désirée van der Heijde, Atul Deodhar, Robert D Inman, et al.
Therapeutic Advances in Musculoskeletal Disease
|
June 9, 2025
Uveitis in patients with axial spondyloarthritis or psoriatic arthritis: a post hoc analysis from placebo-controlled phase III studies with secukinumab
Jan Brandt-Jürgens, Martin Rudwaleit, Frank Behrens, et al.
JAMA Internal Medicine
|
September 12, 2017
Trends and Characteristics of US Medicare Spending on Repository Corticotropin
Daniel M Hartung, Kirbee Johnston, Shelby Van Leuven, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
September 20, 2021
Demyelinating Disease After Exposure to Tumor Necrosis Factor α Inhibitors: A Case Series in a Tertiary Care Center
Nicholas Stienstra, Joel Horton, Michael Lane, et al.
International Journal of Rheumatic Diseases
|
May 26, 2017
Efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis: 52-week pooled results from two phase 3 studies
James C-C Wei, Dominique Baeten, Joachim Sieper, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 25, 2014
Reply: To PMID 25154344
Atul Deodhar, Joachim Sieper, John D Reveille, et al.
Page
of 28
Search research articles
Search
Showing results (91-100 of 272) with videos related to
Sort By:
Page
of 28
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
December 27, 2018
Diffuse Idiopathic Skeletal Hyperostosis, Associated Morbidity, and Healthcare Utilization: A University Hospital Experience
Maanas Tripathi, Divya Rajmohan, Cody Quirk, et al.
Springerplus
|
March 21, 2015
Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy
Kathryn Hobbs, Atul Deodhar, Brian Wang, et al.
JAMA Network Open
|
January 16, 2019
Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin
Daniel M Hartung, Kirbee Johnston, David M Cohen, et al.
Arthritis Research & Therapy
|
May 24, 2024
Time to improvement of pain, morning stiffness, fatigue, and disease activity in patients with ankylosing spondylitis treated with tofacitinib: a post hoc analysis
Victoria Navarro-Compán, Atul Deodhar, Rachid Bahiri, et al.
Arthritis Care & Research
|
June 29, 2012
Comparison of three methods for calculating the Bath Ankylosing Spondylitis Metrology Index in a randomized placebo-controlled study
Désirée van der Heijde, Atul Deodhar, Robert D Inman, et al.
Therapeutic Advances in Musculoskeletal Disease
|
June 9, 2025
Uveitis in patients with axial spondyloarthritis or psoriatic arthritis: a post hoc analysis from placebo-controlled phase III studies with secukinumab
Jan Brandt-Jürgens, Martin Rudwaleit, Frank Behrens, et al.
JAMA Internal Medicine
|
September 12, 2017
Trends and Characteristics of US Medicare Spending on Repository Corticotropin
Daniel M Hartung, Kirbee Johnston, Shelby Van Leuven, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
September 20, 2021
Demyelinating Disease After Exposure to Tumor Necrosis Factor α Inhibitors: A Case Series in a Tertiary Care Center
Nicholas Stienstra, Joel Horton, Michael Lane, et al.
International Journal of Rheumatic Diseases
|
May 26, 2017
Efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis: 52-week pooled results from two phase 3 studies
James C-C Wei, Dominique Baeten, Joachim Sieper, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 25, 2014
Reply: To PMID 25154344
Atul Deodhar, Joachim Sieper, John D Reveille, et al.
Page
of 28